Loading

Pelagos Pharmaceuticals, Inc.

June 05, 2024
Company Presentation
Cardiovascular
Company Presentation Theater 3
Pelagos is a pre-clinical biotech company developing exercise mimetic drugs for diseases of aging. We have 2 small molecule programs targeting previously undrugged nuclear receptors, ERR and REV-ERB, to regulate cellular energetics, mitochondrial biogenesis, and inflammation and increase muscle function and exercise tolerance. Initial indications are heart failure (HFpEF and HFrEF) and obesity with muscle preservation.
Pelagos Pharmaceuticals, Inc.
Company Website: http://www.pelagospharma.com
Lead Product in Development: P109: Rev-Erb Agonist for Heart Failure
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Houston

Company HQ State

Texas

Company HQ Country

United States

CEO/Top Company Official

Dan Watkins

Development Phase of Primary Product

Pre-Clinical
Speakers
Dan Watkins, PhD
CEO
Pelagos Pharmaceuticals, Inc.
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS